Repeated stereotactic radiosurgery for recurrent brain 💓 Repeated gamma knife radiosurgery enables longer tumor

Efficacy of salvage stereotactic radiotherapy for recurrent

Repeated stereotactic radiosurgery for recurrent brain

Repeated gamma knife radiosurgery enables longer tumor control in

Repeat stereotactic radiosurgery as salvage therapy for

Retrospective analysis of salvage surgery for local

Repeat stereotactic radiosurgery for locally recurrent brain

PDF Stereotactic reirradiation for local failure of brain

Repeat Stereotactic Radiosurgery for Locally Recurrent Brain

Advances in radiotherapy for brain metastases PMC

Repeated Stereotactic Radiotherapy for Local Brain Metastases

Radiation necrosis or tumor progression A review of the

Efficacy of salvage stereotactic radiotherapy SRT for locally

Survival and complications of stereotactic radiosurgery PMC


In this article, we reported a case of lung cancer patient with multiple brain metastases treated by repeated Stereotactic Radiotherapy platform—CyberKnife. A 55-year-old male was first treated in the department of Respiratory Medicine center, for a long-term cough and pain in the chest and back. Using x-ray, a mass was detected in the right. Stereotactic Radiosurgery for Residual/Recurrent Nonfunctioning Pituitary Adenomas In 1951, Lars Leksell, a neurosurgeon, devised the concept of SRS. He described SRS as the “closed skull destruction of an intracranial target using ionizing radiation.” 29 Seventeen years later, Leksell treated the first pituitary adenoma patient using the Gamma Knife. 11 oct. 2024 · Background: The main advantages of stereotactic radiotherapy (SRT) are to delay whole-brain radiotherapy (WBRT) and to deliver ablative doses. Despite this efficacy, the risk of distant brain metastases (BM) one year after SRT ranges from 26% to 77% and 20 to 40% of patients required salvage treatment. The role and consequences of reirradiation remain unclear, particularly in terms of survival. 10 oct. 2024 · Conclusion: The present case report demonstrates that CyberKnife therapy plays a significant role in the repeated radiotherapy for multiple metastatic brain tumors. CKSRT can be used as a salvage method in recurrent multiple brain metastases. Keywords: case report, CyberKnife, multiple brain metastases, Re-irradiation, stereotactic radiosurgery. 12 janv. 2024 · Minniti G, Clarke E, Lanzetta G et al (2024) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48. Article Google Scholar Huang X, Zhang X, Wang X et al (2024) A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis. Neurology 95(10):e1392–e1403. We report our overall experience using SRS for the retreatment of locally recurrent brain metastases. Methods: Patients with brain metastases diagnosed between 2024 and 2015 who underwent repeat SRS for local tumor progression following prior SRS were identified. Objectives: To perform a systematic review and meta-analysis of outcomes for patients with locally recurrent brain metastases treated with a repeat course of stereotactic radiosurgery (rSRS). Method: Primary outcomes were 1-year local control(LC) and radionecrosis (RN). Secondary outcomes were 1-year overall survival (OS) and 1-year distant. 1 août 2017 · Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases - ScienceDirect Abstract Introduction Section snippets References (20) Cited by (43) World Neurosurgery Volume 104, August 2017, Pages 589-593 Original Article Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases Paul Koffer 1 2 , Jason Chan 3 , Paul Rava 4 ,. METHODS Between 2024 and 2015, 32 patients were treated with repeat SRS for local recurrence of ≥ 1 brain metastasis following initial SRS treatment. The Kaplan-Meier method was used to estimate time-to-event outcomes including overall survival (OS), local failure, and radiation necrosis. 1 août 2018 · We investigated the outcomes of repeat stereotactic radiosurgery (SRS) for metastatic brain tumors that locally recurred despite previous SRS, focusing on the tumor control. Methods A total of 114 patients with 176 locally recurring metastatic brain tumors underwent repeat SRS after previous SRS. Abstract. Objective: We investigated the outcomes of repeat stereotactic radiosurgery (SRS) for metastatic brain tumors that locally recurred despite previous SRS, focusing on the tumor control. Methods: A total of 114 patients with 176 locally recurring metastatic brain tumors underwent repeat SRS after previous SRS. 1 août 2018 · PDF | Objective: We investigated the outcomes of repeat stereotactic radiosurgery (SRS) for metastatic brain tumors that locally recurred despite | Find, read and cite all the research you need. 1 sept. 2024 · Repeated stereotactic radiosurgery for recurrent brain metastases: An effective strategy to control intracranial oligometastatic disease - ScienceDirect Abstract Introduction Section snippets References (44) Cited by (10) Critical Reviews in Oncology/Hematology Volume 153, September 2024, 103028. 1 nov. 2024 · The optimal management of recurrent brain metastases (BM) after initial stereotactic radiosurgery (SRS) is unknown, and whole brain radiotherapy (WBRT) is often used in this setting. We report outcomes for patients treated with repeat SRS to the same site after local failure (LF) of BM, deferring WBRT. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population. Re-SRT after LR presented excellent local control with acceptable RN rate and improved patients' survival, limited mainly by extracranial and distant brain progression. 19 janv. 2024 · Data of all patients with local failure of initial SRT treated from 2024 to 2019 were retrospectively reviewed and cases treated with salvage SRT were analyzed. We analyzed the impact of patients' and treatment characteristics on overall survival after re-SRT by Kaplan-Meier method and Cox regression models. Local and distant brain. In this study, we assessed the efficacy of salvage stereotactic radiotherapy (SRT) for recurrent glioma. From August 2008 to December 2024, 30 patients with recurrent glioma underwent salvage SRT. The initial histological diagnoses were World Health Organization (WHO) grades II, III, and IV in 6, 9,. Objectives Due to a steadily growing use of stereotactic radiotherapy (SRT) for treatment of brain metastases (BMs), the in-eld failure after an initial stereotaxy is an increasingly frequent problem. Repeat stereotactic radiotherapy (re-SRT) shows encouraging results in terms of local control. 19 janv. 2024 · 10.1007/s12094-020-02544-y Authors: Katarzyna Holub Hospital Clínic de Barcelona G. Louvel Abstract Objectives Due to a steadily growing use of stereotactic radiotherapy (SRT) for treatment. 27 oct. 2017 · Systematic review of the available data to evaluate the efficacy of SRS as a treatment for HGG with regards to median overall survival (OS) and progression-free survival (PFS), in addition to ascertaining the rate of radiation necrosis and other SRS-related major neurological complications. Systematic review of the available data to evaluate the efficacy of SRS as a treatment for HGG with regards to median overall survival (OS) and progression-free survival (PFS), in addition to ascertaining the rate of radiation necrosis and other SRS-related major neurological complications. 4 oct. 2024 · Survival and complications of stereotactic radiosurgery: a systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas. Fetcko K, Lukas RV, Watson GA, Zhang L, Dey M. Medicine (Baltimore) 2017; 96:0. [PMC free article] [Google Scholar]. 20 avr. 2024 · With the increased prevalence of stereotactic radiosurgery (SRS) as standard of care for brain metastasis, understanding the state of this technique and particularly the impact of treatment options that influence delivery accuracy is vital. While challenges to SRS treatments are known, eg, small field dosimetry and patient setup, the. 25 juil. 2024 · This activity reviews the mechanism of stereotactic radiosurgery, evaluates the different devices available, and gives an overview of the indications, procedural technique, and complications. Additionally, this activity highlights the role of the interprofessional team in enhancing care for patients undergoing stereotactic radiosurgery. Overall tumor control rates in the repeated SRS analysis adjusting for the competing risk of death were 70.6%, 50.4%, and 43.1% at 1, 3, and 5 years, respectively. Prior gross total resection was the only independent predictor of overall tumor control after SRS (aHR = 25.62 (1.55-422.1), p = 0.02). 1 juin 2024 · The authors report their data on treatment of GJTs with gamma knife radiosurgery (GKS). Retrospective review and pooled analysis. Fifteen patients (nine female, six male) were treated. 5 mars 2024 · This study aimed to report the characteristic of tumor regrowth after gamma knife radiosurgery (GKRS) and outcomes of repeat GKRS in nonfunctioning pituitary adenomas (NFPAs). Design and Methods This retrospective study consisted of 369 NFPA patients treated with GKRS. 23 juin 2024 · Stereotactic radiosurgery (SRS), such as gamma knife radiosurgery (GKRS), is a well-established treatment option for BM. Based on the evidence established by multiple randomized trials, SRS. Abstract. Introduction: Local failure (LF) following stereotactic radiosurgery (SRS) of brain metastases (BM) may be treated with a second course of SRS (SRS2), though this procedure may increase the risk of symptomatic radionecrosis (RN). 1 sept. 2024 · Brain metastases represent a major indication for stereotactic radiosurgery (SRS), but further study is needed regarding repeat SRS (SRS2) after local or marginal recurrence after prior SRS (SRS1). We report local tumor control (LC) after SRS2 and identify predictors of radiation necrosis (RN) and symptomatic RN (SRN).